@article{Vasileiou_E-2021_24763,
title = {Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study},
author = {Vasileiou, E. and Simpson, C. and Shi, T. and Kerr, S. and Agrawal, U. and Akbari, A. and Bedston, S. and Beggs, J. and Bradley, D. and Chuter, A. and de Lusignan, S. and Docherty, A. and Ford, D. and Hobbs, F. and Joy, M. and Katikireddi, S. and Marple, J. and McCowan, C. and McGagh, D. and McMenamin, J. and Moore, E. and Murray, J. and Pan, J. and Ritchie, L. and Shah, S. and Stock, S. and Torabi, F. and Tsang, R. and Wood, R. and Woolhouse, M. and Robertson, C. and Sheikh, A.},
month = {apr},
year = {2021},
abstract = {The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other countries. Studying the real-world effects of these vaccines is an urgent requirement. The aim of our study was to investigate the association between the mass roll-out of the first doses of these COVID-19 vaccines and hospital admissions for COVID-19.},
pages = {1646-1657},
volume = {397},
issue = {10285},
journal = {The Lancet},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S0140-6736(21)00677-2},
}
